Merck | Income Statement
Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,193,952
863,208
983,446
1,034,807
1,156,648
611,958
Cost of Goods Sold (COGS) incl. D&A
654,141
407,799
490,865
495,742
571,626
401,353
Gross Income
539,812
455,409
492,582
539,065
585,022
210,605
SG&A Expense
311,589
262,057
307,840
324,476
381,894
167,062
EBIT
228,222
193,352
184,742
214,589
203,128
43,544
Non Operating Income/Expense
1,385
6,780
1,755
1,615
5,366
2,863
Interest Expense
-
-
-
-
3,356
-
Pretax Income
234,708
205,058
193,941
214,916
205,785
50,208
Income Tax
59,263
54,683
51,395
61,073
61,107
12,831
Consolidated Net Income
175,445
150,375
142,545
153,843
144,677
37,378
Net Income
175,445
150,375
142,545
153,843
144,677
37,378
Net Income After Extraordinaries
175,445
119,279
142,545
153,843
144,677
1,088,569
Net Income Available to Common
175,445
161,267
142,545
153,843
144,677
139,870
EPS (Basic)
391.60
405.05
2,463.00
343.00
323.00
2,596.71
Basic Shares Outstanding
448
448
58
448
448
448
EPS (Diluted)
391.62
405.07
2,463.34
343.40
322.94
2,596.71
Diluted Shares Outstanding
448
448
58
448
448
448
EBITDA
240,432
204,223
197,903
228,845
219,700
48,611
Non-Operating Interest Income
5,100
4,926
7,444
1,942
647
3,802
About Merck
View Profile
